The Acceleration Arrives: All Segments Speed Up, Guidance Raised Twice, and We Upgrade IBM to Outperform

Results vs. Consensus

Year-over-Year Comparison

Quarter-over-Quarter (the acceleration in one view)

Assessment

Revenue. Seven percent constant-currency growth is the number that changes the story. Last quarter the debate was whether IBM's reported growth was a mix of a hot mainframe cycle and M&A masking soft organic Software; this quarter management put that debate to rest by stating Software accelerated about three points sequentially on an organic basis while the inorganic contribution came down. When the top line accelerates and the composition improves at the same time, the multiple stops being a question of faith.

Margins. The margin story compounded: operating gross margin up 120 bps, operating pre-tax margin up 200 bps to 18.6%, and adjusted EBITDA margin up 290 bps on 22% EBITDA growth, the ninth consecutive quarter of operating pre-tax margin expansion. Segment margins expanded across the board, 420 bps in Infrastructure, 270 bps in Software, 200 bps in Consulting (its highest in three years). This is the productivity flywheel doing exactly what management promised, and it is now visibly self-reinforcing rather than a one-quarter effect.

EPS and cash. Operating EPS of $2.65 (up 15%) on 7% cc revenue again shows the roughly 2x profit-to-revenue leverage that defines the model. Nine-month free cash flow of $7.2B is a record year-to-date margin and supports the raised ~$14B full-year target; management absorbed a $500M year-on-year headwind from last year's QRadar asset-sale proceeds and still grew cash. At the post-print price this is a free-cash-flow yield near 5%, and the raised guide gives us more confidence in the durability of that yield than we had a quarter ago.

Segment Performance

Key portfolio KPIs

Software (+9% cc): organic reacceleration, the crux resolved

Software grew 9% at constant currency with management explicitly attributing the roughly three-point sequential acceleration to organic strength, noting the inorganic contribution actually declined as prior acquisitions wrapped. Automation surged 22% cc on a record HashiCorp bookings quarter; Data grew 7%; and Red Hat grew 12% cc, a two-point deceleration explained by a tough consumption-services comp (~1 point) and core RHEL reverting from an abnormal mid-teens pace to its ~6% model (~1 point). Underneath the Red Hat headline, OpenShift ARR reached $1.8B growing over 30% with bookings near 40%, and virtualization bookings crossed $400M cumulatively with a $700M pipeline. Transaction Processing declined 3% cc but was explicitly guided to return to growth in Q4.

"Software revenue grew 9%, fueled by accelerating organic growth, up a few points since last quarter ... This wasn't an inorganic contribution. In fact, our inorganic contribution came down." — James Kavanaugh, CFO

Assessment: This is the single most important disclosure of the quarter and it directly resolves the bear point we anchored our Hold on. Red Hat's deceleration is the one yellow flag, but management's decomposition (subscription bookings up ~20%, RPO accelerating) makes a Q4 and 2026 reacceleration credible rather than hopeful. The organic story is now demonstrated, not promised.

Infrastructure (+15% cc): the mainframe cycle keeps compounding

Infrastructure accelerated to 15% cc as IBM Z rose 59% cc, its highest third-quarter revenue in nearly two decades, on continued z17 strength; the company has now shipped over 130% of the z16 cycle's MIPS at the equivalent point. Distributed Infrastructure swung to +8% cc (from -17% in Q2) on a broad storage recovery, and the forthcoming Spyre accelerator (Q4) will bring generative-AI inferencing on-box to IBM Z.

"IBM Z delivered its highest third-quarter revenue in nearly two decades, up 59% year to year ... purpose-built for AI and hybrid cloud, with breakthrough capabilities in real-time inferencing." — James Kavanaugh, CFO

Assessment: The z17 cycle is tracking well ahead of the record-setting z16, and the 130%+ MIPS figure is the leading indicator for the Transaction Processing software monetization that should build through 2026-2027. This is now a two-year visible tailwind rather than a single strong quarter.

Consulting (+2% cc): the inflection we did not underwrite

Consulting returned to growth at 2% cc, which management called a "marked inflection point," with both sub-segments showing sequential momentum and segment margin up 200 bps year to date to its highest level in three years. The GenAI consulting book exceeded $1.5B in the quarter with project count more than doubling year over year, now over 22% of a $31B backlog. Signings fell 5% on continued large-renewal comp pressure, but net-new client penetration rose double digits again (over 300 new clients year to date).

"Consulting returned to growth in the third quarter with revenue up 2% ... marking a positive inflection point in performance." — James Kavanaugh, CFO

Assessment: We modeled Consulting flat and treated any inflection as upside; that upside arrived a quarter earlier than we expected. The pivot to a "people plus software" delivery model is turning AI's threat to labor-based services into a margin tailwind, though we would still characterize Consulting as a stabilized, market-growth business rather than an engine.

Key Topics & Management Commentary

Overall Management Tone: Management was the most confident it has been across our coverage, opening with the claim of the fastest revenue growth in several years and returning repeatedly to the theme that all segments accelerated at once. The posture on the prior quarter's sore point, organic Software, was proactive rather than defensive: the CFO volunteered the organic-versus-inorganic decomposition before it was pressed. Where the call was most forward-leaning was on 2026, where both executives offered a segment-by-segment acceleration framework while carefully labeling it directional rather than guidance.

Organic Software reacceleration

The quarter's defining disclosure was that Software's acceleration was organic. Management framed year-to-date Software growth of about 8.5% as carrying roughly two points from the GenAI book, with the sequential improvement driven by the recurring-revenue base ($23.2B ARR, up 9%) rather than acquisitions, whose contribution declined as HashiCorp and DataStax began to wrap.

"About two points of that growth is coming out from our GenAI book of business. ... we accelerated about three points organically quarter to quarter. This wasn't an inorganic contribution." — James Kavanaugh, CFO

Assessment: This is the linchpin of the upgrade. An organic reacceleration, coupled with an ARR base guided to exit the year at double-digit growth, converts the double-digit Software guide from an M&A-and-hope construction into a genuinely organic trajectory. It is the exact evidence we said we needed.

The 2026 Software acceleration framework

Pressed on whether Software can hold or accelerate double-digit growth into 2026 as the HashiCorp anniversary approaches, management laid out a four-part organic bridge: Red Hat reaccelerating toward mid-teens on ~20% bookings growth, Transaction Processing turning to low-single-digit growth as z17 capacity monetizes, Automation staying double-digit even as HashiCorp's acquired revenue laps, and Data holding mid-to-high single digits, with any M&A additive on top.

"We do expect to see Red Hat returning to mid-teens or close to mid-teens growth. ... I expect to see TP grow ... low single digits for sure into next year. ... automation in the double digits for sure." — Arvind Krishna, CEO

Assessment: The 2026 bridge is more credible than the 2025 version was a quarter ago because three of its four planks (organic Software, Consulting inflection, mainframe monetization) are now showing in the actuals rather than the pipeline. It is still a forward framework, but it rests on demonstrated momentum.

Free cash flow durability and 2026 conversion

The lead question probed whether the raised ~$14B free-cash-flow guide contains one-offs that would not repeat in 2026. Management's answer emphasized quality: the growth is driven by adjusted EBITDA (up ~$2.5B year on year), the company absorbed a $500M QRadar-related headwind, and conversion has run in the mid-to-high 120s percent for four consecutive years.

"Those underlying fundamentals ... deliver a sustainable realization number ... in the mid to high one twenties. ... we've been there for four years in a row already. So we can handle that." — James Kavanaugh, CFO

Assessment: The free-cash-flow engine is the bedrock of the thesis and the answer was reassuring: EBITDA-driven, not working-capital-flattered, with a multi-year track record of high conversion. This is the pillar that limits downside and funds both the dividend and the M&A optionality.

AI monetization and the government shutdown

Asked about the revenue trajectory of AI and the risk from the federal government shutdown, the CEO characterized shutdown exposure as "de minimis" because IBM's federal footprint runs essential systems (Social Security payments, VA benefits, ERP), and framed the $9.5B AI book as increasingly real revenue as consulting backlog executes and software subscriptions build.

"We see a de minimis impact to IBM ... these are running critical systems. Payments for social security, benefits for the VA. All of these are considered essential." — Arvind Krishna, CEO

Assessment: The shutdown reassurance is credible given the mission-critical nature of IBM's government work, and it removes a near-term overhang. The AI-monetization framing is consistent with the segment data: AI is now a measurable contributor (~2 points of Software growth), not just a signings headline.

Productivity flywheel and Project Bob

Management reiterated the $4.5B run-rate savings target exiting 2025, up from an original $2B goal set in 2023, and pointed to Project Bob, an internal AI software-development tool now used by more than 8,000 IBM developers reporting average productivity gains of 45%, as a live "client zero" proof point.

"We have more than 8,000 developers within IBM that are using Project Bob, reporting productivity gains averaging 45%. Another powerful client zero use case." — Arvind Krishna, CEO

Assessment: The productivity program keeps outrunning its own targets ($2B to $4.5B), and using IBM as the reference deployment for the software it sells is a genuinely differentiated go-to-market. This is the most durable, macro-independent pillar of the margin story.

Hyperscaler relationship: partner, not competitor

On whether hyperscaler AI growth is a threat, the CEO reframed IBM as a direct beneficiary: IBM is a large CoreWeave client and a heavy user of AWS, Azure, and GCP, and it deploys its software stacks and consulting on top of hyperscaler and neocloud infrastructure (including Groq and, in private instances, for regulated clients). The mainframe and storage portfolios are themselves AI-infrastructure beneficiaries.

"We are actually the direct beneficiary of the hyperscaler growth of AI capability and capacity as enterprises use this capability." — Arvind Krishna, CEO

Assessment: This is a coherent answer to the most common structural bear worry (that IBM is disintermediated by the clouds). Positioning as the enterprise deployment and governance layer on top of any infrastructure plays to IBM's heterogeneity and its regulated-industry install base.

M&A discipline and appetite for a larger deal

On capital allocation, the CEO reiterated a multi-year framework (mid-$20B-plus of M&A flexibility over three years) and three hard criteria for any sizable deal: strategic fit within hybrid cloud and AI, revenue synergy that lifts the target's growth inside IBM, and accretion to cash by the end of year two. He declined to rule out a larger, Red-Hat-scale transaction but emphasized it would have to meet all three tests, not be pursued for size.

"Anything that is of size has to fit three criteria. It has to fit with the strategy ... there has to be synergy ... and ... we like it to become accretive to cash by the end of the second year." — Arvind Krishna, CEO

Assessment: The framework is disciplined and the track record (Red Hat's accretion and free-cash-flow contribution) earns management some benefit of the doubt. The residual risk is a large, dilutive deal that resets the balance sheet; nothing this quarter suggests that, but it stays on our watch list given the stated appetite.

Guidance & Outlook

Where last quarter's guide was "hold the top line, raise everything below it," this quarter IBM raised the top line too, to more than 5% cc, alongside free cash flow (~$14B), adjusted EBITDA (mid-teens growth), and operating pre-tax margin expansion (over a point). Management also gave unusually specific Q4 segment shape: Software double-digit growth, Consulting growth similar to Q3, and Transaction Processing returning to growth.

Implied Q4 ramp: The raised full-year cc revenue guide implies Q4 growth roughly in line with or slightly ahead of Q3, with Software accelerating to double digits (helped by lapping last year's elevated Red Hat consumption comp) and TP flipping positive. This is a back-half finish that now has demonstrated momentum behind it.

Street at: Management said it is "comfortable with consensus estimates for constant currency revenue growth and profitability" for Q4. The raised guides move the full-year bar up, and consensus had already been rising through the year.

Guidance style: Two consecutive quarters of raises, now including the revenue line, mark a shift from IBM's habitual reaffirm-and-beat toward genuine confidence. The pattern of setting the bar conservatively and clearing it remains intact, but the willingness to raise revenue is the tell that the underlying momentum is real.

Analyst Q&A Highlights

Free cash flow quality and 2026 conversion

The opening question tested whether the ~$14B free-cash-flow guide is inflated by one-offs and whether conversion can stay above 120% in 2026. Management emphasized the EBITDA-driven, high-quality nature of the cash and the absorption of a QRadar headwind, and reaffirmed a mid-to-high 120s conversion track record.

Q: "This sort of implies free cash flow is up double digits in '25 and your conversion rates are around 125% ... is there anything that could preclude free cash flow from growing a few points higher than sales growth ... into 2026?"
— Amit Daryanani, Evercore ISI

A: "Accelerating revenue growth ... driving operating leverage and it's leveraging an efficient balance sheet. We see all that continuing to play out in 2026 ... a sustainable realization number ... in the mid to high one twenties. ... we've been there for four years in a row already." — James Kavanaugh, CFO

Assessment: Management gave a substantive, quantified answer rather than a deflection, and the four-year conversion track record backs it. The free-cash-flow engine is the least-contested and most durable part of the thesis.

AI revenue inflection and government-shutdown exposure

A multi-part question asked whether AI is reaching a revenue inflection into 2026 and whether the federal shutdown poses Q4 risk, with a clarification request on organic Software and Transaction Processing. Management called the shutdown de minimis and reiterated the organic Software decomposition and the Q4 TP return to growth.

Q: "Are we hitting some kind of inflection that we should see meaningful upside into 2026 on the AI front? And ... the impact of the federal government shutdown ... And ... clarify the organic growth in software ... and expectations for transaction processing."
— Wamsi Mohan, Bank of America

A: "We see a de minimis impact to IBM ... And definitely the AI piece is a strong contributor to the software growth and ... a big piece of why consulting is beginning to return to growth. ... calling a return to growth in TP in the fourth quarter with the strong pipeline we got." — Arvind Krishna, CEO / James Kavanaugh, CFO

Assessment: The same analyst who pressed the organic-deceleration point in July got a much stronger answer this quarter. AI is now a measurable growth contributor across both Software and Consulting, and the shutdown overhang was credibly dismissed.

Can Software hold or accelerate double digits into 2026?

A direct question on whether Software can sustain double-digit growth into 2026 as the HashiCorp anniversary approaches drew a segment-by-segment organic acceleration framework from the CEO, with the CFO reinforcing that acquisitions have historically driven a higher organic engine through synergy.

Q: "You do wrap the Hashi acquisition in the spring ... Are there signs that it can accelerate from here? Obviously with Red Hat decelerating a little ... if you can keep double-digit next year or even accelerate?"
— Ben Reitzes, Melius Research

A: "We do expect to see Red Hat returning to mid-teens or close to mid-teens growth ... I expect to see TP grow ... low single digits ... automation in the double digits for sure ... data and AI portfolio grow in the mid to high single digits." — Arvind Krishna, CEO

Assessment: The 2026 framework is coherent and, critically, each plank now has actuals behind it. The Red Hat reacceleration is the swing factor; the ~20% bookings and accelerating RPO make it plausible but not yet proven.

Organic versus inorganic in the 2026 growth rates

A clarification-plus-strategy question asked whether the 2026 growth rates were organic and how IBM views the hyperscaler AI opportunity. The CEO confirmed the rates were largely organic (tuck-ins included, larger M&A additive) and reframed IBM as a beneficiary of hyperscaler growth through software and consulting attach.

Q: "I just wanted to confirm those were all organic growth rates or whether they included M&A embedded in them. And ... do you see a similar opportunity for IBM Cloud to capture long-term infrastructure-driven demand?"
— Eric Woodring, Morgan Stanley

A: "The growth rates I mentioned ... are largely organic without having any significant M&A. ... we are actually the direct beneficiary of the hyperscaler growth of AI capability ... enterprises use this capability ... on top of the [Groq] infrastructure, we tend to put our software stacks." — Arvind Krishna, CEO

Assessment: Confirming the 2026 rates as largely organic is the second explicit organic reassurance of the call, and the hyperscaler-as-partner framing neutralizes the disintermediation worry. Both strengthen the upgrade case.

M&A strategy and appetite for a larger deal

On capital allocation, the question probed whether IBM would consider a larger, transformative acquisition. The CEO reiterated the three-criteria discipline (strategic fit, synergy, two-year cash accretion) and declined to rule out scale while insisting it would not pursue size for its own sake.

Q: "Would you consider undertaking a somewhat larger, transformative transaction not quite as big as you did with Red Hat, but of sort of similar scale relative to your overall portfolio?"
— Jim Schneider, Goldman Sachs

A: "We will never rule anything out but it has to meet all the criteria that we just laid out. It is not for size alone. Red Hat allowed us to enter a new space ... helped accelerate IBM's overall growth rate." — Arvind Krishna, CEO

Assessment: The discipline is reassuring and the Red Hat precedent supports the framework, but the open door to a larger deal is the one place where the capital-allocation story carries tail risk. We would scrutinize any transaction that resets leverage, though nothing suggests one is imminent.

Consulting book-to-bill and the AI mix

The closing exchange pressed on Consulting's sub-1.0 trailing-six-month book-to-bill and the software/consulting split of the AI book. Management defended the inflection by pointing to backlog quality over signings, attributing the signings softness to low-margin renewals and highlighting rising net-new penetration and GenAI mix.

Q: "Two quarters in a row now where we are seeing the book to bill ratio a touch below one ... why we shouldn't be worried especially considering ... around 30% of signings you mentioned are AI which I believe are longer duration?"
— Mark Newman, Bernstein

A: "Those signings numbers have been driven down ... based on lower large deal renewal volume ... at best no revenue realization ... underneath that ... net new business penetration ... up double digits ... GenAI ... over 22% of our backlog, 30% of our signings, 12% of our revenue, that's what's inflecting the growth." — James Kavanaugh, CFO

Assessment: The backlog-over-signings framing is analytically sound (renewals are dilutive), and the rising GenAI mix and net-new penetration support the inflection. Still, a persistently sub-1.0 short-term book-to-bill is the one metric to keep watching in Consulting.

What They're NOT Saying

1. A clean 2026 revenue guide: Management offered a rich qualitative 2026 framework and confirmed the growth rates are "largely organic," but explicitly declined to put a number on next year. The confidence is evident; the accountability of a figure is deferred to January.
2. Red Hat's path back to mid-teens with specificity: The 12% cc print and the "returning to mid-teens or close to mid-teens" language leave a gap. Management decomposed the deceleration convincingly, but did not commit to a quarter for the reacceleration, only that bookings and RPO support it.
3. The absolute software AI revenue, not just the book: The AI "book of business" (>$9.5B) is a cumulative signings-and-ACV metric; management quantified the software piece as approaching $2B inception-to-date but still does not disclose recurring AI software revenue as a clean run-rate.
4. Consulting's short-term book-to-bill trajectory: The trailing-twelve-month figure (1.14 last quarter) is cited, but the sub-1.0 six-month reading was addressed only by reframing to backlog. A timeline for book-to-bill to cross back above 1.0 was not given.
5. The size or timing of the next acquisition: With mid-$20B-plus of three-year M&A flexibility and an open door to a larger deal, management gave criteria but no pipeline color, leaving the balance-sheet trajectory dependent on an undisclosed deal calendar.

Market Reaction

• Pre-print setup: IBM entered at $287.51, roughly 3% below its 52-week closing high of $294.78, up 30.8% year-to-date and 23.8% over twelve months, and up 5.9% over the trailing 30 days. The setup was rich but had consolidated somewhat since the July peak.
• Reaction session (October 23): Shares gapped down 7.8% at the open ($264.95) on the same reflex that hit the stock in July, then reversed almost entirely to close at $285.00, down just 0.9% ($2.51). Volume of 16.7M was 3.4x the 30-day average, concentrated in the morning selloff and the afternoon recovery.
• Context: The S&P 500 rose 0.6% on the session, so the intraday reversal was IBM-specific: buyers stepped into the gap-down rather than the market lifting the stock.

The tape told a more constructive story than the July print did. The knee-jerk gap-down was the familiar "slowing cloud growth" headline reaction to Red Hat's two-point deceleration, but this time the market reversed course within the session as investors digested the breadth of the quarter: accelerating revenue across all four segments, a double guidance raise, and an explicit organic-Software reacceleration. A 7.8% opening drop fully bought back is a meaningfully different signal than July's 7.6% close at the lows; it says the marginal holder is now willing to look through a single soft data point rather than sell it. That shift in the reaction function is part of why we are comfortable upgrading into a full valuation rather than waiting for a pullback that the market is increasingly unwilling to give.

Street Perspective

Debate: Is the organic acceleration durable or a favorable-comp artifact?

Bull view: The bull case holds that the organic reacceleration is structural, driven by an ARR base exiting the year at double-digit growth, a Red Hat bookings surge that precedes revenue by several quarters, and a Transaction Processing monetization cycle just beginning; 2026 should accelerate, not fade.

Bear view: The bear camp argues that part of the Q3 acceleration reflects easy year-ago comps and a hot mainframe cycle that will normalize, that Red Hat, the highest-quality asset, is decelerating, and that the double-digit Software guide still depends on a Q4 hockey stick.

Our take: We now side with the bulls, where a quarter ago we did not. The decisive change is management's explicit statement that acceleration was organic while inorganic contribution fell, which is not a comp artifact. Red Hat's deceleration is the legitimate residual risk, but the bookings and RPO data make its reacceleration the base case. The composition of growth improved at the same time the rate accelerated; that combination is what turned our Hold into an Outperform.

Debate: Does the full valuation still cap the return?

Bull view: At roughly 25x forward operating earnings and a ~5% free-cash-flow yield, IBM is reasonably priced for a business inflecting to mid-single-digit-plus revenue growth with nine straight quarters of margin expansion, a rising dividend, and a self-funded productivity engine; the multiple can hold as estimates rise.

Bear view: The bears counter that 25x is a full multiple for a company that will still grow revenue in the mid-single digits, that the re-rating has already happened, and that upside now requires either estimate beats or multiple expansion, both harder from here.

Our take: This is the strongest remaining bear argument and the reason our conviction is a 6, not an 8. But total return does not require multiple expansion: a ~2.4% dividend, high-single-digit operating-EPS growth, and a flat multiple on rising estimates can plausibly beat the S&P over twelve months, and the raised guides bias estimates up. We are paying a fair price for a genuinely inflecting franchise, which is an Outperform, not a table-pound.

Debate: Is IBM a beneficiary or a victim of the AI infrastructure boom?

Bull view: IBM benefits directly, deploying its software and consulting on top of hyperscaler and neocloud capacity, while its mainframe and storage franchises are themselves AI-infrastructure plays (on-box inferencing via z17 and Spyre, storage for AI data).

Bear view: Skeptics see IBM as structurally disintermediated by the clouds and frontier-model providers, with its differentiation confined to legacy install bases and its AI "book" heavily weighted to lower-margin consulting.

Our take: The enterprise-deployment-layer positioning is credible and consistent with IBM's decades-long middleware role, and the mainframe's evolution into an AI inference platform is a genuine, under-appreciated angle. We do not think IBM leads the AI platform race, but it does not need to; being the governance-and-integration layer for regulated enterprises across any infrastructure is a defensible, monetizable position.

Model Update Needed

Valuation impact: At the post-print $285.00, IBM trades at roughly 25x our ~$11.25 FY25 operating EPS and a ~5% free-cash-flow yield. On rising estimates and a stable-to-modestly-higher multiple justified by the improved growth composition, we see a 12-month fair-value range around $300-320, implying mid-to-high single-digit price upside plus the dividend, enough to clear our Outperform bar against the index.

Thesis Scorecard Post-Earnings

Overall: Thesis strengthened materially. The core bear point, that reported growth was M&A-assisted and organically soft, was directly refuted by an organic reacceleration, and every bull pillar advanced. The only unresolved items are Red Hat's specific reacceleration path and the still-full valuation, neither of which is sufficient to hold us back given a double guidance raise and improving reaction function.

Action: Upgrade to Outperform from Hold. Own the inflection: accelerating organic revenue, expanding margins, a rising free-cash-flow guide, and a 2026 setup with visible momentum. We would revisit the rating on evidence that Red Hat fails to reaccelerate or that the Q4 Transaction Processing return-to-growth slips, and we would trim into a multiple that expanded well beyond the high-20s without commensurate estimate revisions.